Ribociclib (RIB) plus fulvestrant (FUL) in postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from MONALEESA-3

Affiliation auteurs!!!! Error affiliation !!!!
TitreRibociclib (RIB) plus fulvestrant (FUL) in postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC): Results from MONALEESA-3
Type de publicationJournal Article
Year of Publication2018
AuteursSlamon DJ, Neven P, Chia SKL, Im S-A, Fasching PA, DeLaurentiis M, Petrakova K, Bianchi GValeria, Esteva FJ, Martin M, Pivot X, Vidam G, Wang Y, Lorenc CKaren Rodr, Miller MKristine, Taran T, Jerusalem GHeinrich M
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2018.36.15_suppl.1000